(lp0
S'Biocept Reports Fourth Quarter and Full Year 2016 Financial Results PR Newswire  - Mar 7, 2017 SAN DIEGO, March 7, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports ...'
p1
aS'Valeant Pharmaceuticals Intl Inc  Running Low On Gas, Biocept Inc (BIOC ... Smarter Analyst - Mar 8, 2017 In the biotech-verse, Valeant Pharmaceuticals Intl Inc  and Biocept Inc  are in opposite standing. According to one of the best analysts on the Street, who has lately been zooming in with a vengeance on the troubled biotech giant ...Wall Street Movers News  Valeant Pharmaceuticals Intl Inc , Biocept ... - Wall Street Times '
p2
aS'Biocept to Release 2016 Fourth Quarter and Full Year Financial Results and ... PR Newswire  - Feb 21, 2017 SAN DIEGO, Feb. 21, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that ...'
p3
aS'Biocept Appoints Michael Terry Senior Vice President Commercial Operations PR Newswire  - Feb 15, 2017 SAN DIEGO, Feb. 15, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces the&nbsp;...'
p4
aS'Biocept to Present at the 27th Annual Oppenheimer Healthcare Conference Yahoo Finance - Mar 15, 2017 SAN DIEGO, March 15, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that David&nbsp;...Catalyst Pharmaceuticals  Stock: Continues Gaining On Biocept  Deal - CNA Finance '
p5
aS"Analyst's Proposition on Biocept, Inc. , W&amp;T Offshore, Inc.  The USA Commerce - 23 hours ago Shares of Biocept, Inc.  surged 3.43% to $2.11. During the trading on 03/14/2017, Company's stock ranged from $2.04 to $2.22."
p6
aS'Biocept Inc  Stockholders Get Letter From The CEO Journal Transcript - Feb 27, 2017 A letter sent by the Michael Nall, the chief executive officer of Biocept Inc , to shareholders has sought to underscore the strong position the pharmaceutical company is currently in, in the area of liquid biopsy.'
p7
aS"Buy, Sell or Hold? Analysts Approach: Biocept, Inc. , Avon Products, Inc ... The USA Commerce - Mar 9, 2017 Shares of Biocept, Inc.  surged 0.44% to $2.27. During the trading on 03/08/2017, Company's stock ranged from $2.23 to $2.75.Pay Too Much Attention To Two Stock Analyst Ratings: Biocept, Inc. (NASDAQ ... - The Voice Registrar"
p8
aS'Roth Capital Brokers Boost Earnings Estimates for Biocept Inc  Chaffey Breeze - Mar 11, 2017 Biocept logo Biocept Inc  - Equities researchers at Roth Capital lifted their Q1 2017 earnings per share  estimates for shares of Biocept in a research note issued on Wednesday.Biocept Inc  Upgraded to Buy at Zacks Investment Research - Sports Perspectives'
p9
aS'Biocept Inc  FY2016 Revenue Jumps Over Five-Fold YoY StockNewsUnion - Mar 8, 2017 Biocept Inc  a major commercial provider of liquid biopsy assessments intended to offer physicians with clinically actionable data to enhance the outcomes of cancer patients released financial report for the quarter and the full year ...Biocept, Inc.  Releases Earnings Results, Beats Expectations By $0.07 EPS - The Cerbat GemBiocept, Inc.  recently purchased by insider Neff Edward A. - Post Analyst'
p10
a.